These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 1686725

  • 1. TP53 gene mutations and 17p deletions in human astrocytomas.
    Chung R, Whaley J, Kley N, Anderson K, Louis D, Menon A, Hettlich C, Freiman R, Hedley-Whyte ET, Martuza R.
    Genes Chromosomes Cancer; 1991 Sep; 3(5):323-31. PubMed ID: 1686725
    [Abstract] [Full Text] [Related]

  • 2. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas.
    Willert JR, Daneshvar L, Sheffield VC, Cogen PH.
    Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455
    [Abstract] [Full Text] [Related]

  • 3. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 4. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 May 15; 52(10):2987-90. PubMed ID: 1349850
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas.
    Wu JK, Darras BT.
    Neurol Res; 1992 Mar 15; 14(1):39-44. PubMed ID: 1351257
    [Abstract] [Full Text] [Related]

  • 7. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas.
    el-Azouzi M, Chung RY, Farmer GE, Martuza RL, Black PM, Rouleau GA, Hettlich C, Hedley-Whyte ET, Zervas NT, Panagopoulos K.
    Proc Natl Acad Sci U S A; 1989 Sep 15; 86(18):7186-90. PubMed ID: 2571151
    [Abstract] [Full Text] [Related]

  • 8. Timing of p53 mutations during astrocytoma tumorigenesis.
    del Arco A, García J, Arribas C, Barrio R, Blázquez MG, Izquierdo JM, Izquierdo M.
    Hum Mol Genet; 1993 Oct 15; 2(10):1687-90. PubMed ID: 8268922
    [Abstract] [Full Text] [Related]

  • 9. Loss of constitutional heterozygosity in human astrocytomas.
    Van de Kelft E, De Boulle K, Willems P, Martin JJ, Selosse P, Van der Auwera B.
    Acta Neurochir (Wien); 1992 Oct 15; 117(3-4):172-7. PubMed ID: 1357919
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A.
    J Neuropathol Exp Neurol; 1997 Oct 15; 56(10):1098-104. PubMed ID: 9329453
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.
    Fults D, Tippets RH, Thomas GA, Nakamura Y, White R.
    Cancer Res; 1989 Dec 01; 49(23):6572-7. PubMed ID: 2573417
    [Abstract] [Full Text] [Related]

  • 13. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 14. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar 01; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 16. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D, Pedone C.
    Neuro Oncol; 2000 Apr 01; 2(2):71-9. PubMed ID: 11303623
    [Abstract] [Full Text] [Related]

  • 17. TP53 alterations and clinical outcome in low grade astrocytomas.
    Kraus JA, Bolln C, Wolf HK, Neumann J, Kindermann D, Fimmers R, Forster F, Baumann A, Schlegel U.
    Genes Chromosomes Cancer; 1994 Jun 01; 10(2):143-9. PubMed ID: 7520269
    [Abstract] [Full Text] [Related]

  • 18. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors.
    Wu JK, Ye Z, Darras BT.
    Neurosurgery; 1993 Nov 01; 33(5):824-30; discussion 830-1. PubMed ID: 7903434
    [Abstract] [Full Text] [Related]

  • 19. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.
    Acta Neuropathol; 2001 Apr 01; 101(4):321-33. PubMed ID: 11355303
    [Abstract] [Full Text] [Related]

  • 20. Deletion mapping of chromosome 19 in human gliomas.
    von Deimling A, Nagel J, Bender B, Lenartz D, Schramm J, Louis DN, Wiestler OD.
    Int J Cancer; 1994 Jun 01; 57(5):676-80. PubMed ID: 8194874
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.